| 2019-12-26 | Sale | Groupon, Inc. GRPN | director | 420,248 0.0736% | $2.34 | $981,909 | -48.54% | |
| 2019-07-22 | Mirum Pharmaceuticals, Inc. MIRM | 10 percent owner | 900,000 5.3814% | $15.00 | $13.5M | +5.09% | ||
| 2019-05-09 | Trevi Therapeutics, Inc. TRVI | 10 percent owner | 5M 34.6117% | $10.00 | $50M | -42.9% | ||
| 2019-05-07 | Regulus Therapeutics Inc. RGLS | 10 percent owner | 1.14M 6.1239% | $1.08 | $1.23M | -40% | ||
| 2018-09-07 | Adaptimmune Therapeutics plc ADAP | 10 percent owner | 30M 4.8721% | $1.67 | $50M | -57.66% | ||
| 2018-07-30 | Liquidia Corporation LQDA | 10 percent owner | 545,455 4.6996% | $11.00 | $6M | +38.27% | ||
| 2018-05-10 | Sale | GlycoMimetics, Inc. GLYC | 10 percent owner | 19,078 0.0446% | $17.81 | $339,779 | -26.95% | |
| 2018-03-27 | Adaptimmune Therapeutics plc ADAP | 10 percent owner | 12M 2.1988% | $1.92 | $23M | -12.28% | ||
| 2018-03-27 | TRACON Pharmaceuticals, Inc. TCON | 10 percent owner | 707,964 4.6641% | $2.70 | $1.91M | -8.89% | ||
| 2018-03-26 | Adaptimmune Therapeutics plc ADAP | 10 percent owner | 1.14M 0.2007% | $1.90 | $2.18M | -14.01% | ||
| 2018-03-23 | Adaptimmune Therapeutics plc ADAP | 10 percent owner | 588,180 0.1062% | $1.95 | $1.14M | -12.52% | ||
| 2018-03-22 | Adaptimmune Therapeutics plc ADAP | 10 percent owner | 1.74M 0.308% | $1.90 | $3.31M | -12.12% | ||
| 2018-03-21 | Adaptimmune Therapeutics plc ADAP | 10 percent owner | 209,688 0.0355% | $1.81 | $379,640 | -10.61% | ||
| 2018-02-26 | Sale | ARCA biopharma, Inc. ABIO | 10 percent owner | 1.46M 11.9306% | $0.50 | $731,273 | +22.22% | |
| 2017-12-08 | Sale | Senseonics Holdings, Inc. SENS | 10 percent owner | 32,850 0.0283% | $2.59 | $85,200 | +30.96% | |
| 2017-12-07 | Sale | Senseonics Holdings, Inc. SENS | 10 percent owner | 12,100 0.0106% | $2.61 | $31,628 | +31.78% | |
| 2017-12-06 | Sale | Senseonics Holdings, Inc. SENS | 10 percent owner | 94,695 0.0817% | $2.64 | $249,995 | +28.79% | |
| 2017-11-27 | Sale | Appian Corporation APPN | 10 percent owner | 1.14M 2.1156% | $19.49 | $22.2M | +42.78% | |
| 2017-11-20 | Sale | Appian Corporation APPN | 10 percent owner | 5.64M 11.2735% | $19.49 | $109.94M | +53.66% | |
| 2017-10-10 | Rhythm Pharmaceuticals, Inc. RYTM | 10 percent owner | 550,000 1.3734% | $17.00 | $9.35M | +9.57% |